Articles From: Galectin Therapeutics to Present at Aegis Capital Corporation 2014 Healthcare and Technology Conference to Game-changing hydraulic fracturing technology, reduces emissions by 99%


2014/7/22
Novel, rapidly dissolving oral PharmFilm® enables faster absorption, increased convenience and better compliance for patients.
Sign-up for Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film investment picks
PORTLAND, Ore., July 1, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced the notice of allowance of a U.S. Patent for NeuVax™ (nelipepimut-S) covering the use of NeuVax alone or in combination to prevent recurrence of any HER2/neu expressing tumor having a fluorescence in situ hybridization (FISH) rating of less than about 2.0. NeuVax is a peptide immunotherapy for the prevention of cancer recurrence and is Galena's lead development agent in multiple ongoing and planned clinical trials.
Sign-up for Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) investment picks
2014/8/11
Abstral® (fentanyl) sublingual tablet net revenue was $2.3 million in Q2 2014 and $4.5 million in 1H 2014.
Sign-up for Galena Biopharma Reports Second Quarter 2014 Results investment picks
PORTLAND, Ore., Sept.
Sign-up for Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
PORTLAND, Ore., July 29, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that the Company will report its second quarter financial results on Monday, August 11, 2014 after the close of the financial markets.
Sign-up for Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 investment picks
Galena State Bank and Trust Co., a subsidiary of Heartland Financial USA, Inc. (NASDAQ:HTLF) announced today that it will change its name to “Illinois Bank & Trust.” Simultaneously, the bank announced plans to merge with its sister bank, Riverside Community Bank, located in Rockford, IL.
Sign-up for Galena State Bank Announces Plan to Rebrand As Illinois Bank & Trust investment picks
BEDFORD, Texas , Aug.
Sign-up for Galenfeha, Inc. Announces Clearance for DTCC Eligibility investment picks
2014/7/25
BEDFORD, Texas , July 25, 2014 /PRNewswire/ -- The management team of Galenfeha, Inc. announced today that the company's common stock will commence trading on Monday, July 28, 2014 , on the OTCBB under the ticker symbol GLFH.
Sign-up for Galenfeha, Inc. Announces Stock To Begin Trading On July 28 investment picks
2014/7/17
Cost containment, talent acquisition two biggest challenges cited by respondents ITASCA, Ill.
Sign-up for Gallagher Releases 2nd Annual Benefits Strategy & Benchmarking Survey investment picks
Global well-being improvement leader Healthways (NASDAQ: HWAY) and world-leading management consulting firm Gallup have achieved the next milestone in their joint venture to advance the science of well-being measurement and improvement.
Sign-up for Gallup-Healthways Well-Being 5™ Delivers Next-Generation Population Health Measurement to Individuals and Organizations Worldwide investment picks
TEL AVIV, Israel , July 22, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Sign-up for Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders investment picks
2014/7/25
-- Conference Call and Webcast Today at 8:30 a.m. EDT/5:30 a.m. PDT --
Sign-up for Galmed Pharmaceuticals Reports First Half 2014 Financial Results investment picks
TEL AVIV, Israel , July 21, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Sign-up for Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 investment picks
2014/9/4
Dragon-themed Mobile Slot Puzzle Game with Real Money Gaming Mechanics will be demoed at G2E with Eight other titles for new platform LOS ANGELES , Sept.
Sign-up for Gamblit Gaming Partners With NS Studio To Bring "Epic Slots" To Mobile Devices investment picks
2014/9/30
Revealing 10 New Mobile Titles with Real Money Gaming Mechanics at Global Gaming Expo 2014 LAS VEGAS , Sept.
Sign-up for Gamblit Gaming Unveils Innovative Platform Offering New Revenue Stream investment picks
GAMCO Investors, Inc. (NYSE:GBL) announced today that its Board of Directors approved a quarterly dividend of $0.06 per share to all of its Class A and Class B shareholders, payable on September 30, 2014 to its Class A and Class B shareholders of record on September 16, 2014.
Sign-up for GAMCO Board Approves Quarterly Dividend of $0.06 Per Share investment picks
GAMCO Investors, Inc. (“GAMCO”) (NYSE:GBL) today reported its 2014 second quarter results including revenues of $108.3 million, net income of $29.0 million and earnings of $1.13 per diluted share.
Sign-up for GAMCO Investors, Inc. Reports Record Second Quarter Results investment picks
The Board of Trustees of the GAMCO Natural Resources, Gold & Income Trust (NYSE:GNT) (the “Fund”) declared monthly cash distributions of $0.09 per share for each of October, November, and December 2014.
Sign-up for Gamco Natural Resources, Gold & Income Trust Continues Monthly Distributions, Declaring Distributions of $0.09 Per Share investment picks
2014/8/28
Campaign includes new commercial, online sweepstakes and partnership with 1991 Heisman Trophy winner Desmond Howard COLUMBUS, Ga.
Sign-up for Game On! Aflac Duck Launches Season-Long Football Campaign investment picks
2014/10/1
HOUSTON, Oct.
Sign-up for Game-changing hydraulic fracturing technology, reduces emissions by 99% investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Galectin Therapeutics to Present at Aegis Capital Corporation 2014 Healthcare and Technology Conference to Game-changing hydraulic fracturing technology, reduces emissions by 99%
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices